We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
HelloDone automates conversations across messaging apps such as WhatsApp, Facebook Messenger, and Instagram for the transportation, home delivery and utility sectors. HelloDone stresses that its Software as a Service (SaaS) enables more than 80% of inbound queries to be resolved automatically between customers of retailers and global carriers. HelloDone states that its portal drastically reduces the customer service burden and creates new dialogues with the customer for enhanced revenues. The company claims that it launched its portal in October 2020 and onboarded its first client in four months, followed by signing large online retailers such as Charles Tyrwhitt and Footasylum. It has also signed contracts with leading UK fast fashion groups and major US retailers. HelloDone is tracking £330,000 worth of Annual Recurring Revenue (ARR) for 2021 and forecasting revenues of £65 million by 2025. They state they will use the investment to arrange flagship brands signed, build on evidence/success metrics and build scale and pace ready for a planned Series-A in mid-2022.
days to go: Expired investment: £700,003
Care Line Live is an award-winning revolutionary monitoring and management platform for Home Care Agencies. CLL is a client-based system that enables home care agencies to run their businesses from any place. It reduces administration, automates processes, easily rosters client visits and improves efficiency and productivity by giving the client more Time to Care. It increases client and carer satisfaction, provides accessible and responsive support, increases compliance for CQC purposes, generates higher profits through improved efficiency and capacity. The future product road map includes integration with 3rd party home automation platforms that will allow home care agencies to offer further services to their clients, such as secure key-less entry.
days to go: Expired investment: £367,000
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
Edozo goal is to transform data storage, data sharing and workflow efficiency for commercial property professionals. 
days to go: Expired investment: £350,000
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
End-to-end platform that enables content owners to profitably deliver video content direct-2-user in a complex multi-device world.
days to go: Expired investment: £510,000
GoInStore is a first person shopping experience that allows online visitors to experience a store as if they were in the store. You are able to engage with a retail associate from that store in real-time via a one-way video stream and a two-way audio connection.
days to go: Expired investment: Withheld
Orthogem is a UK based manufacturer of synthetic bone grafts. Synthetic bone grafts are substitutes for human bone grafts and are designed to replace bone that has been lost. Orthogem have recently started to produce their product in a putty form in order to keep up with the changes in the market. 
days to go: Expired investment: £722,784
Network Gaming, with backing from Betfair's founder, is an inventive betting innovation company. They develop unique, responsible sports prediction products, supported by a team experienced in industry giants like FanDuel and Betfair. Their offerings help media and betting firms stand out, driving customer acquisition, while prioritizing responsible gaming and dynamic engagement.
days to go: Expired investment: £250,000
MyCustomerLens uses artificial intelligence to connect and summarise customer feedback garnered from multiple sources such as surveys, online reviews, interviews on its real-time feedback aggregation platform. MyCustomerLens argues survey providers, research agencies, and online reviews collect disconnected data. It further points out that their cumulative outputs get stuck in silos and are rarely updated, which firms find cumbersome and time-consuming. MyCustomerLens claims that its portal provides actionable insights firms need to protect and grow their revenues in the wake of remote working and digital transformations brought forth by Covid-19. MyCustomerLens aspires to dominate the estimated $23 billion Customer Experience Management (CEM) market by 2027. It asserts that its targeted businesses are the UK's 26,000 legal, accounting and consulting firms, with banking and healthcare firms in the pipeline. MyCustomerLens states they will use the investment to expand their core team and enable investments in marketing and partnerships that will accelerate its growth.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph